SummaryCompaniesLawyers say public-interest powers can be used to extract commitmentsPlurality concerns appear weak but could delay deal, they sayPossible remedies include commitments on news, children's TVLONDON, July 2 (Reuters) - Britain's threat to intervene in the $110 billion Paramount-Warner deal could be less about blocking the transaction than extracting commitments on UK news, children's TV and investment, with the cost of any delay increasing the government's leverage.
Culture minister Lisa Nandy said on Tuesday she was leaning towards intervening in Paramount Skydance Corp's (PSKY.O), opens new tab proposed takeover of Warner Bros Discovery (WBD.O), opens new tab on public-interest grounds centred on a possible reduction in media plurality.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Lawyers and media advisers said the public-interest case for intervention appeared limited. But the prospect of a review could encourage Paramount to offer voluntary commitments rather than risk delaying the deal and increasing costs.
Possible concessions could include commitments to preserve independent news provision and UK children's programming, as well as pledges to maintain or expand Warner's British production footprint, including Leavesden studios.
The deal has already been approved in a string of countries, with Kuwait, Austria and Australia the latest to give it the green light.
The U.S. Department of Justice has cleared the deal, but California, New York and other U.S. states are preparing a lawsuit to block it, sources have told Reuters.
Paramount has offered remedies to the European Commission ahead of its decision deadline of July 7.
COST OF DELAYNandy said she was concerned the merger could reduce the range of voices available to British audiences, particularly in children's programming, news and streaming.
Paramount has agreed to pay Warner shareholders an additional 25 cents a share "ticking fee" for every quarter the deal remains unfinished after September 30, a provision that would cost it about $650 million in cash every three months.
That gives the government leverage because even a relatively limited public-interest review could delay completion and increase Paramount's costs.
Claire Enders, founder and chief executive of Enders Analysis, said the move had come as a surprise given that the grounds for intervention appeared relatively weak.
But she said Nandy, an ally of Andy Burnham, who is set to become Britain's next prime minister this month, appeared to be using the prospect of delay to secure commitments.
"Substance is never that important," she said. "What really matters is making big promises, way in advance of events. And this intervention seems to be structured in order to attain that."
BRINKMANSHIP AND BLUFFBritain's Competition and Markets Authority is already examining the deal under standard competition metrics such as market share. It will either clear it or refer it for a more detailed investigation by August 7.
Luke Stillman, a managing director at advisory firm Madison and Wall, said the competition and public-interest processes were separate.
"One is very quantitative, while the new inquiry would be on softer, more open to interpretation, grounds," he said.
Competition lawyer Ronan Scanlan, a partner at Steptoe, said Nandy's move, likely coordinated with Burnham, could signal a desire to appear tougher on global deals with a UK dimension.
He said there was an element of brinkmanship and bluff.
"Ultimately this is likely sabre rattling with a view to setting down a marker going forward for global deals and extracting some concessions, in this case around children's and general programming in the UK," he said.
Paramount owns Britain's Channel 5 free-to-air broadcaster, while Warner owns CNN International.
In news, a simple concession could be a commitment to retain independent news producer ITN as Channel 5's provider rather than switching to CNN.
In children's TV, the deal combines Nickelodeon and Cartoon Network. Paramount could offer to maintain UK children's programming commitments.
Warner also owns major film and TV production facilities in Britain, including Leavesden studios, where "Barbie" and the Harry Potter movies were made. A commitment to retain or expand those operations could help address government concerns.
The companies have until July 6 to respond to Nandy.
"I suspect that this one-week turnaround is to basically punch them hard and see whether they cough up," Enders said.
POLITICAL FLUXMark Kelly, chief executive of MKI Global Partners, said the merger was unfolding during a period of political flux in Britain, with Prime Minister Keir Starmer expected to be replaced by the more left-leaning Burnham on July 20.
Standing up to a major media company was likely to serve Nandy well politically, he said. She has already met Paramount boss David Ellison earlier this year to discuss the deal.
"One might presume that if Paramount were to approach her with the right stance over the summer, giving her sufficient ammunition to claim she has extracted concessions, (...) this can still be resolved reasonably quickly," he said.
Whether or not the plurality concerns ultimately justify intervention, the case illustrates how governments can use public-interest powers to shape the terms of global mergers rather than simply block them.
Reporting by Paul Sandle, Additional reporting by Muvija M and Annousha Sakoui. Editing by Kate Holton and Mark Potter
Our Standards: The Thomson Reuters Trust Principles., opens new tab
AI agents will soon have the ability to match the capabilities of human traders, Robinhood CEO Vlad Tenev predicts.
The power of agentic technology — AI that can carry out tasks for users — has been touted as potentially transformational by many in the tech sector, with industry giants including OpenAI and Anthropic racing to develop such products.
Robinhood unveiled tools in May that allow AI agents to trade stocks and make purchases on users' behalf.
"The idea behind agentic trading…[is] every capability a human can do will be available to an AI agent," Tenev told CNBC's Karen Tso on Thursday.
"I was doing programmatic trading as an institutional player before starting Robinhood, and what you don't realize is a large portion of trades are already automated and AI powered."
"But that type of intelligence and complexity has been out of reach from everyday people," he added.
"The end state of agentic trading at Robinhood is to give the everyday person access to the same tools, the same computation, the same power that institutional investors in high-frequency trading firms have been enjoying for several decades."
On Wednesday, Robinhood said it would launch crypto trading in the U.K. as it expanded its offering in Europe.
Shares of Robinhood were up around 2% in Thursday premarket trading after an 8% pop on Wednesday, taking the group's market cap $98 billion at close. Shares are down around 5% in 2026.
Robinhood stock
In April, Robinhood missed expectations for first-quarter profit as crypto-driven market volatility weighed on trading activity. Market conditions have since improved, with easing Middle East tensions and strong equity markets supporting retail trading activity.
That same month, Robinhood announced it would act as a broker and trustee for the yet-to-be-released Trump Accounts, in partnership with U.S. Treasury and BNY Mellon.
"The goal is to make this the best consumer product that the government's ever been associated with," said Tenev.
Robinhood serves nearly 28 million customers across 38 countries and three continents, the company said in a statement.
Earlier this month, Robinhood cut 10% of its workforce as it looked to operate more efficiently.
"Robinhood's business has never been stronger," Tenev said in a note to employees shared on social media platform X.
"We cannot default to operating as a heavily-layered organization. We must be a lean, hyper-focused team," he added.
Rocket Lab (RKLB 1.43%) stock has posted big valuation gains over the last year, rising roughly 178% as of this writing. The gains have been propelled by strong sales growth, new and expanded partnerships, and general interest surrounding space stocks.
But the stock has seen a substantial pullback from its lifetime valuation high reached this May and currently trades down roughly 34.5% from its peak. Despite the valuation contraction, the company still has a market capitalization of roughly $56.7 billion and is valued at approximately 62 times this year's expected sales.
With Rocket Lab's big expansion opportunities and high-risk valuation profile in mind, where will the company be 10 years from now?
Image source: Getty Images.
Does Rocket Lab have what it takes to keep winning big? When it comes to charting the outlooks for companies operating at the frontiers of transformative new technologies and services, there's inevitably a lot of speculation. Rocket Lab has a strong position in the rocket-launching services space, trailing only Space Exploration Technologies (SpaceX), but there's a lot of guesswork when it comes to forecasting how the category will unfold over the long term.
On the other hand, Rocket Lab's strengths in launch technologies and services look promising -- and the company has been making some smart moves to capitalize on them. The space tech specialist recently announced it is purchasing telecom company Iridium Communications in an $8 billion deal that should significantly expand the business and dramatically improve its financial picture.
Today's Change
(
-1.43
%) $
-1.45
Current Price
$
100.20
The move will move Rocket Lab into more direct competition with SpaceX's Starlink business, but that actually looks like a smart move. With Rocket Lab already offering strong rocket launch services, it makes sense to move more directly into satellite and communications businesses to capitalize on substantial cost synergies.
So while Rocket Lab stock remains very risky, I think it offers potentially massive upside for investors willing to hold it over a decade.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy.
SummaryOneMain Holdings remains resilient amid macro volatility, delivering 2.5% returns since the last coverage and justifying my reiterated buy rating.OMF's risk is mitigated by 55% of personal loans being secured, a $2.8B loan loss allowance, and fixed-rate lending, supporting credit quality.My updated Dividend Discount Model yields a target price of $88.79; with a 20% margin of safety, my buy zone is up to $71.04.OMF offers an attractive ~7% dividend yield, with yields remaining compelling even if the stock appreciates to my conservative target. Kamonchanok Jaikaew/iStock via Getty Images
Two and a half months after my previous coverage, OneMain Holdings, Inc. (OMF) remained resilient. Recent events like the Middle East War and inflation reacceleration did not erode its value. It even delivered 2.5% returns
911 Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of OMF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced that its board of directors has authorized a new share repurchase program, under which the Company may repurchase up to 10% of total issued and outstanding Ordinary Shares and/or American depositary shares ("ADSs") for up to US$20 million over the next 12 months, effective as of the date hereof.
The Company's proposed repurchases may be made from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, including through Rule 10b5-1 trading plans, depending on market conditions and in accordance with applicable laws, rules and regulations. The timing and amount of repurchases, if any, will be subject to market conditions, trading price, trading volume and other factors. The Company's board of directors will review the share repurchase program periodically and may authorize adjustments to its terms and size. The Company expects to fund the repurchases from its existing cash balance.
About Yiren Digital
Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. Following the regulatory filing of its in-house developed Large Language Model Zhiyu, and the significant enhancement of its MagiCube Agent platform, Yiren Digital is establishing a new growth engine to accelerate its evolution into an AI-native, multi-industry operating platform extending beyond traditional financial services. For more information, please visit https://ir.yiren.com.
Safe Harbor Statement
This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "aim," "anticipate," "believe," "estimate," "expect," "hope," "going forward," "intend," "ought to," "plan," "project," "potential," "seek," "may," "might," "can," "could," "will," "would," "shall," "should," "is likely to" and the negative form of these words and other similar expressions. This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions. Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of the Company, and which could cause actual results to differ materially from those expressed or implied in such statements. Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.
The logo of medical implants maker Zimmer Biomet is seen at a plant in Winterthur, Switzerland, November 16, 2018. Picture taken November 16, 2018. REUTERS/Moritz Hager/File Photo Purchase Licensing Rights, opens new tab
CompaniesBENGALURU/HYDERABAD, July 2 (Reuters) - - Medical device maker Zimmer Biomet (ZBH.N), opens new tab plans to hire 500 employees over the next three years for its newly opened technology centre in Bengaluru, a senior executive said, as the U.S.-listed company expands its presence in India.
The hires will span software engineering, product design, research and development, and functions such as quality, regulatory and finance, Jehanzeb Noor, chief strategy, business development, innovation and transformation officer, said on Wednesday.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
About two-thirds of the hires will be in technology roles, with the remainder in support functions, Noor said, adding that the company was not constrained on hiring and could significantly expand headcount to thousands in the future.
The expansion comes as India strengthens its position as a hub for global capability centres. Healthcare companies including Novo Nordisk (NOVOb.CO), opens new tab, AstraZeneca (AZN.L), opens new tab and Eli Lilly (LLY.N), opens new tab use their India centres for research and development, clinical data analysis, regulatory work and technology.
GCC consultant ANSR estimates revenue from India's global capability centres will rise 12% to $84 billion in the financial year ending 2026, the firm told Reuters.
Zimmer Biomet, whose key markets include the United States, Europe and Japan, makes orthopedic implants for knee, hip and shoulder replacements, as well as surgical and robotic devices for musculoskeletal conditions.
"We want to make sure that we have a centre that has all the appropriate functions running together so we can drive innovation and bring that back to our surgeons, care teams and patients," Chief Information and Technology Officer Shaun Braun said.
The company said the centre would focus heavily on artificial intelligence, with applications spanning robotics, surgical planning and research and development, as it looks to expand the use of AI in its products and speed up development.
Reporting by Sai Ishwarbharath B in Bengaluru and Rishika Sadam in Hyderabad; Editing by Nivedita Bhattacharjee
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Rishika leads Reuters’ coverage of India’s pharmaceutical and healthcare sector. Her reporting focuses on key themes such as the emergence of weight-loss drugs, the country’s drug regulatory framework and manufacturing quality standards, and developments shaping India’s pharmaceutical exports to major markets including the United States and Europe. She also covers the country’s rapidly growing hospital industry. With nearly a decade of experience in journalism, Rishika has previously reported extensively on Indian politics, national elections, and on social affairs and criminal justice.
Sen. Elizabeth Warren is asking Eric Trump to confirm whether his family will resume legal action against Capital One over allegations it de-banked family-linked accounts, The Post has learned.
CAMBRIDGE, Mass., July 02, 2026 (GLOBE NEWSWIRE) -- Akamai Technologies, Inc. (NASDAQ: AKAM), the cybersecurity and cloud computing company that powers business online, announced today that the company will hold a conference call for investors on Thursday, August 6, 2026, at 4:30 p.m. ET. The call will include the company’s second quarter 2026 financial results and may include forward-looking financial guidance from management. The call will also be broadcast live via the internet at Akamai’s Investor Relations page.
The live dial-in information for the conference call is:
U.S. only: (833) 634-5020International: (412) 902-4238Password: Akamai Technologies call
In addition, a replay of the call will be available for two weeks following the conference by calling (855) 669-9658 (or (412) 317-0088 for international calls) and using Conference ID: 8525174. The archived webcast of this event may be accessed through the Akamai website.
About Akamai
Akamai is the cybersecurity and cloud computing company that powers and protects business online. Our market-leading security solutions, superior threat intelligence, and global operations team provide defense-in-depth to safeguard enterprise data and applications everywhere. Akamai's full-stack cloud computing solutions deliver performance and affordability on the world's most distributed platform. Global enterprises trust Akamai to provide the industry-leading reliability, scale, and expertise they need to grow their business with confidence. Learn more at akamai.com and akamai.com/blog, or follow Akamai Technologies on X and LinkedIn.
July 02, 2026 06:00 ET | Source: The Ensign Group, Inc.
SAN JUAN CAPISTRANO, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of (i) “Las Ventanas de Socorro”, a 126-bed skilled nursing facility located in Socorro, Texas, and (ii) “Los Arcos del Norte Care Center”, a 124-bed skilled nursing facility located in El Paso, Texas. The real estate was acquired by subsidiaries of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company, and the facilities are operated by Ensign-affiliated tenants. The acquisition was effective as of July 1, 2026.
“We are excited to continue our incredible year in Texas with the acquisition of these excellent facilities”, said Barry Port, Ensign's Chief Executive Officer. “We are always looking to expand our presence in Texas, and these facilities are tremendous adds to our operations and Standard Bearer’s real estate footprint”, he added.
Andy Ashton, President of Keystone Care LLC, Ensign’s Texas-based subsidiary, added, “Both facilities have fantastic teams of caregivers, and we are so excited to begin serving our residents and their families in the El Paso area.”
These acquisitions were effective July 1, 2026, and bring Ensign's growing portfolio to 398 healthcare operations, which includes 48 senior living operations, across 17 states. Ensign subsidiaries, including Standard Bearer, own 183 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, senior living and other healthcare related businesses throughout the United States.
About Ensign™
The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 398 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Huntsman (NYSE: HUN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Olin.
Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
Huntsman shareholders will receive 0.5476 shares in Olin for every one (1) share of Huntsman. Upon completion of the transaction, Olin shareholders will own approximately 54.5% and Huntsman shareholders will own approximately 45.5% of the combined company.
Huntsman insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Huntsman by imposing a significant penalty if Huntsman accepts a competing bid. We are investigating the conduct of the Huntsman board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today it has acquired Thymmune Therapeutics, Inc. (Thymmune), a privately held, preclinical stage biotechnology company developing scalable, regenerative thymic cell therapies for the potential treatment of post-transplant organ tolerance, immunodeficiencies, and autoimmune diseases.
The thymus is a critical organ for the development and proper function of key parts of the immune system, including training T-cells, which are essential for fighting infections and other diseases. Thymmune has a proprietary process for converting human-induced pluripotent stem cells (iPSC) into thymic cells, which — once inside the body — mature into cell types that can restore healthy T-cell function.
Thymmune’s lead candidate, THY-100, is in preclinical development for congenital athymia, an ultra-rare and life-threatening condition in which infants are born without a functional thymus. Animal studies have shown that treatment with THY-100 results in the in vivo formation of a neo-thymus that is capable of facilitating T-cell development. The clinical proof of concept and further development of THY-100 has the potential to broaden thymic regenerative medicine approaches for transplant tolerance, serious immune-mediated diseases, and enhanced longevity for older adults with diminished T-cell function.
“Thymmune’s platform complements United Therapeutics’ broader mission to expand the supply of transplantable organs, building on our UThymoKidney™ clinical development program and our growing strength in immunomodulatory therapeutics,” said Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer of United Therapeutics. “By restoring or modulating T-cell receptor diversity, Thymmune’s technology could make fundamental contributions to human health care and potentially resolve the root causes of dozens of life-threatening diseases.”
“Thymmune was founded to harness the biology of the thymus to restore immune function for patients with serious immune-mediated diseases,” said Stan Wang, M.D., Ph.D., Chief Executive Officer and Founder of Thymmune Therapeutics. “United Therapeutics shares our conviction that regenerative medicine can transform the lives of patients, and we believe its leadership in organ alternatives and cell-based technologies makes it the ideal partner to advance our platform toward broad clinical impact.”
Under the terms of the agreement, United Therapeutics acquired Thymmune for $140 million in cash, subject to certain post-closing adjustments, plus potential earn-out payments to former Thymmune equityholders of up to $160 million based upon the achievement of certain clinical and regulatory milestones by the end of 2031.
About United Therapeutics
Founded by CEO Martine Rothblatt to discover a cure for her daughter's life-threatening rare disease, pulmonary arterial hypertension, United Therapeutics transforms the treatment of rare diseases and pioneers alternatives to expand the supply of transplantable organs. From our innovative therapies to our groundbreaking manufactured organs, we are bold and unconventional. We move quickly from scientific theory to practical technologies that can save lives. As a public benefit corporation, even our legal structure reflects our commitments. We serve patients, act with integrity, create long-term shareholder value, and operate with sustainable practices that protect the future we are working to build. Visit us at www.unither.com and follow us on LinkedIn, Facebook, and Instagram.
Forward-Looking Statements
Statements included in this press release that are not historical in nature are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, statements regarding our plans to develop THY-100 and other products based on Thymmune’s technology, including the potential to broaden thymic regenerative medicine approaches for transplant tolerance, serious immune-mediated diseases, and enhanced longevity for older adults with diminished T-cell function, the potential for Thymmune’s technology to support our organ manufacturing programs, the potential for Thymmune’s technology to make fundamental contributions to human health care and potentially resolve the root causes of dozens of life-threatening diseases, the potential earn-out payments to the former Thymmune stockholders, our goals of expanding the supply of transplantable organs, developing practical technologies that can save lives, creating long-term shareholder value, and operating with sustainable practices. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could cause actual results to differ materially from anticipated results. Consequently, such forward-looking statements are qualified by the cautionary statements, cautionary language, and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of July 2, 2026, and assume no obligation to update or revise the information contained in this press release whether because of new information, future events, or any other reason.
UTHYMOKIDNEY is a trademark of United Therapeutics Corporation.
Shares of Alnylam Pharmaceuticals (ALNY +0.44%) have dropped 24% so far this year (through June 30). The biotech company is still a darling of Wall Street analysts, with 14 of 29 analysts following it listing the stock as a buy and seven listing it as a strong buy as I write this. The average price target is $436, about 45% above the June 30 closing price.
Since 2018, the company has brought to market six RNA interference (RNAi) therapeutics, genetic medicines that use RNA interference to inhibit specific disease-associated genes. Here's why things are looking good for the stock, and one note of caution.
Image source: Getty Images.
Alnylam is showing explosive revenue growth In the first quarter, product revenue surged 121% year over year to $1.04 billion, fueled primarily by Alnylam's transthyretin amyloidosis (ATTR) franchise, which grew 153% to $910 million. The driver for that growth was Amvuttra, an injectable therapy used to treat polyneuropathy (damage of multiple nerves throughout the body) in adults with hereditary transthyretin-mediated amyloidosis (hATTR).
Alnylam reported a huge jump in profitability, with earnings per share (EPS) of $1.51, compared to a loss per share of $0.14 in the same period a year ago.
The company's full-year 2026 guidance calls for combined net product revenue of between $4.9 billion and $5.3 billion, up 71% year over year at the midpoint. Alnylam is rapidly transitioning from a high-burn clinical biotech into a highly profitable, self-sustaining commercial powerhouse.
Today's Change
(
0.44
%) $
1.33
Current Price
$
302.37
Its products are expanding into new indications While Alnylam has done well in treating rare orphan diseases, its pipeline is on the cusp of penetrating mainstream, high-volume therapeutic markets. New data reinforces Amvuttra's profile as a robust, first-line treatment for cardiomyopathy, setting up a massive commercial launch. Cardiomyopathy affects 0.2% of the U.S. population, and in 40% of cases, leads to heart failure.
Partnering with Roche Holding (RHHBY 2.01%), Alnylam has also developed zilebesiran to treat hypertension, which impacts nearly half of the adults in the U.S.
Zilebesiran and nucresiran are in phase 3 trials -- the first to treat hypertension and the second to treat ATTR. Zilebesiran is unique in that it treats a common condition but in a different manner, as an RNAi therapeutic targeting liver-expressed angiotensinogen and requiring dosing only a few times a year. Nucresiran is in phase 3 trials both to treat hATTR with polyneuropathy, and to treat ATTR-CM.
Another therapy, cemdisiran, is licensed to Regeneron Pharmaceuticals. Among its phase 3 trials are one to treat the autoimmune disorder myasthenia gravis and another to treat the rare blood disease paroxysmal nocturnal hemoglobinuria.
Unlike traditional small molecules or biologics that face immediate patent cliffs, Alnylam's RNAi delivery platforms form a deep technological moat. And its RNAi approach allows it to quickly replicate success from one liver-targeted disease to another with highly predictable clinical translation.
It is aggressively maintaining this edge by deploying artificial intelligence (AI), notably via a strategic AI collaboration with private biotech company Inceptive Nucleics, to accelerate the discovery of next-generation RNAi structures.
A note of caution Even with its tumble this year, the stock is trading at 75 times trailing earnings. That's high for a biotech, particularly one that isn't consistently profitable. Much of the share price is already factoring in the continued commercial uptake of Amvuttra. However, aggressive pricing pressure from competitors such as Pfizer or BridgeBio Pharma could trigger a sharp drop in the price.
The experts are right In the long run, this is a solid stock, even though it trades at a relatively high valuation. The company is already profitable, is growing revenue and earnings, and has a few new therapies on the cusp of commercialization. It has a unique delivery system that will help it retain patent protection. And it is branching out beyond rare diseases into areas such as heart disease and high blood pressure, which have larger patient populations.
Going on company guidance, its forward price-to-earnings (P/E) ratio is just below 30, meaning the stock isn't that expensive given its potential.
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Payoneer (NASDAQ: PAYO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Nuvei.
Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
Payoneer stockholders will receive $7.40 per share in cash, representing a total transaction equity value of approximately $2.75 billion. Payoneer insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Payoneer by imposing a significant penalty if Payoneer accepts a competing bid. We are investigating the conduct of the Payoneer board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Bio-Techne (NASDAQ: TECH) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Merck.
Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
Bio-Techne shareholders will receive $73 per share in cash, representing a total enterprise value of approximately $11.3 billion. Bio-Techne insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Bio-Techne by imposing a significant penalty if Bio-Techne accepts a competing bid. We are investigating the conduct of the Bio-Techne board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- The Catastrophe and Risk Solutions group at Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, estimates economic losses from the June 24, 2026 earthquakes in Venezuela will likely exceed USD 10 billion. Verisk notes a higher degree of uncertainty than usual in estimating the insured share of industry losses because of Venezuela's macroeconomic conditions, elevated inflation, low insurance penetration, and sanctions-related market complexities.
Earthquake Sequence and Impacts
On June 24, Venezuela was struck by a rare earthquake doublet near Yumare-Morón in Yaracuy state, approximately 100 miles west of Caracas. A magnitude 7.2 foreshock was followed just 39 seconds later by a magnitude 7.5 mainshock, making it the strongest earthquake to impact Venezuela since 1900. The shallow strike-slip rupture occurred along the San Sebastián fault system within the tectonically active boundary zone between the Caribbean and South American plates and was subsequently followed by more than 430 recorded aftershocks.
Damage was most severe in the Caracas metropolitan region and the coastal state of La Guaira, where an estimated 1,400 buildings were destroyed. Significant destruction was also reported across Aragua, Carabobo, and Yaracuy states. Communities including Puerto Cabello, Catia La Mar, Maiquetía, San Felipe, Los Teques, Petare, Valencia, and Baruta experienced severe shaking, according to U.S. Geological Survey intensity estimates.
Modeling Information
Because of Venezuela's economic environment, Verisk notes greater uncertainty than is typical for an industry loss estimate. Factors contributing to this uncertainty include assumptions regarding earthquake insurance take-up rates, ongoing inflationary pressures, and the challenges associated with accurately valuing insured assets in a rapidly changing economic environment.
The modeled insured loss estimates do not include losses resulting from fire-following, landslides, sprinkler leakage, loss adjustment expenses, damage to uninsured properties or infrastructure, extra-contractual obligations, hazardous waste cleanup, vandalism, or civil commotion, whether directly or indirectly caused by the event. The estimates also exclude losses associated with civil engineering (railway) risks, marine cargo and marine hull risks, aviation risks, transit warehouse risks, personal accident risks, and other non-modeled sources of loss.
Building Stock and Earthquake Vulnerability
Today, the majority of residential buildings in Venezuela's urban areas are constructed of masonry, including reinforced masonry, confined masonry, and unreinforced masonry structures. Reinforced concrete is the predominant construction type in mid- and high-rise residential buildings, particularly in major urban centers such as Caracas.
Although modern engineering standards exist, seismic performance varies significantly due to local construction practices, material quality, and enforcement of building codes.
Insurance Market in Venezuela
Venezuela's insurance and reinsurance sector remains relatively small and highly concentrated compared to many global markets. The industry continues to operate under challenging macroeconomic conditions characterized by elevated inflation, currency depreciation, regulatory complexity, and limited market capacity.
These conditions create additional uncertainty when estimating insured losses following a catastrophe. Variations in earthquake insurance penetration, coverage levels, and insured property values can materially influence the ultimate insured share of economic losses resulting from the earthquake sequence.
About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, catastrophic events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses.. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work. For more, visit Verisk.com and the Verisk Newsroom.
CoStar Group (NASDAQ: CSGP), an S&P 500 company and the global leader in real estate marketplaces, information, analytics and 3D digital twin technology today
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Cummins Inc. (CMI - Free Report) : This power solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.6% over the last 60 days.
Analog Devices, Inc. (ADI - Free Report) : This integrated circuit company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.
WidePoint Corporation (WYY - Free Report) : This technology management services company has seen the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.
Concrete Pumping Holdings, Inc. (BBCP - Free Report) : This concrete pumping and waste management company has seen the Zacks Consensus Estimate for its current year earnings increasing 41.7% over the last 60 days.
Clear Secure, Inc. (YOU - Free Report) : This identity verification company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Even in what appears to be a frothy market environment, investors can find beaten-down stocks to analyze. For instance, shares in this apparel company recently traded at a gut-wrenching 78% off their record from December 2023 (as of June 29).
But it wasn't always this way. This consumer discretionary stock soared 321% in the five-year run leading up to that peak.
Here's one reason you might want to consider buying shares today.
Image source: Getty Images.
Lululemon Athletica (LULU +1.94%) has done a fantastic job losing the market's conviction. The stock has gotten so crushed that the valuation is hard to ignore now. Investors can buy shares at a forward price-to-earnings ratio of just 10.6, less than half the S&P 500 index's multiple.
Lululemon's growth has weakened dramatically. Revenue increased 4% in the first quarter of fiscal year 2026 (ended May 3), with sales in the critical U.S. market down 4%, likely due to a combination of competitive forces, disappointing product releases, and inflationary pressures.
Today's Change
(
1.94
%) $
2.22
Current Price
$
116.40
The rational perspective, after learning that the stock has lost three-fourths of its value, is that this is a dying business. That's not true.
Lululemon still reports robust profitability, with a gross margin of 54.2% last fiscal quarter. Its brand name, known for premium merchandise, is a key competitive advantage. And it possesses long-term growth potential, especially in China.
If you're a patient investor willing to hold for five years or longer, Lululemon deserves some attention.
Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Lululemon Athletica Inc. The Motley Fool has a disclosure policy.
Matson (MATX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Nuvalent (NASDAQ: NUVL) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with GSK plc.
Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
Nuvalent stockholders will receive $124 per share and the aggregate equity value of the transaction is approximately $10.6 billion. Nuvalent insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Nuvalent by imposing a significant penalty if Nuvalent accepts a competing bid. We are investigating the conduct of the Nuvalent board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Key Takeaways MSM says restructuring is mostly complete as volume trends and sales execution begin to improve.Q3 sales rose 7.8% YoY to $1.047B, while adjusted EPS increased to $1.43 from $1.08.MSM guided Q4 average daily sales growth of 6.5%-8.5% and adjusted operating margin of 10.0%-10.8%. MSC Industrial Direct Co., Inc. (MSM - Free Report) used its fiscal third-quarter earnings call to argue that its turnaround is moving past disruption and into execution. Management pointed to improving volume trends, firmer national account performance and better operating leverage as signs that recent structural changes are beginning to translate into cleaner results.
The central message was less about the quarter itself and more about what comes next. Executives said the company is now positioned to use a better industrial backdrop, tighter sales discipline and a leaner cost base to push toward stronger growth and a mid-teens operating margin over time.
MSM Puts New Metrics at the CenterPresident and CEO Martina McIsaac said MSC Industrial is now managing the business against a narrower set of targets: sales per rep per day, sales per total headcount, year-over-year volume improvement, adjusted operating margin expansion, adjusted incremental margin and return on invested capital. She framed those measures as the clearest way for investors to judge whether the turnaround is gaining traction.
McIsaac kept her tone measured. She said MSC Industrial is not yet producing breakout results, but described the quarter as a collection of smaller operational wins that indicate the company is heading in the right direction.
That matters because management is asking investors to focus less on one quarter’s headline numbers and more on whether productivity, volume and margin discipline are improving together.
MSC Industrial Says Sales Disruption Is EasingMcIsaac said the sales force optimization completed in December created noise in fiscal second quarter results, but that headwind is now largely behind the company. She cited improving average daily sales among affected customers and an inflection in national accounts as evidence that coverage and execution are stabilizing.
McIsaac also said sales per rep per day improved by the high teens year over year, even with 225 fewer field heads. That was presented as proof that MSC Industrial is generating more productivity from a smaller commercial footprint.
The remaining task, by management’s account, is to close the gap between customers least affected by the redesign and those still rebuilding relationships after rep changes or vacancies.
MSM Still Relies on Price but Wants More VolumeThird-quarter sales increased 7.8% year over year to $1.05 billion, beating the Zacks Consensus Estimate of $1.03 billion by 1.74%. Adjusted EPS rose to $1.43 from $1.08 a year earlier, surpassing the Zacks Consensus Estimate of $1.28.
Interim CFO Greg Clark said price remained the main growth driver, contributing 720 basis points to sales growth, while volume added 50 basis points. Even so, management repeatedly stressed that volume improved through the quarter and turned positive across customer types.
McIsaac also made clear that MSC Industrial does not want the story to remain price-led. She told analysts the company would prefer to keep gross margin around the 40% to 41% range and use efficiency gains and pricing discipline to support competitiveness and volume growth.
MSC Industrial Pushes Productivity HarderClark said adjusted operating margin reached 10.6%, up from 9% a year ago, while adjusted operating expenses fell 150 basis points as a percentage of sales. He attributed the improvement to productivity and headcount actions, lower freight expense and reduced duplicate commission costs under the new sales structure.
McIsaac said the bigger internal benchmark remains headcount efficiency. She told analysts that MSC Industrial is still about 1,000 heads heavy relative to peer benchmarks at current revenue levels and said progress should be tracked through sales per head and absolute non-sales headcount.
That benchmark turned into one of the call’s most important themes because management tied future margin expansion to AI, automation and process redesign rather than to gross margin expansion alone.
MSM Sees Broader Signs of RecoveryManagement said industrial demand is improving, though still unevenly. McIsaac described the recovery as being around the third inning and pointed to changing summer shutdown patterns, especially in automotive, as one of the clearest behavioral signals that conditions are getting better.
Clark also highlighted stronger solutions activity. Vending machine installations rose 7% to about 30,800, in-plant programs increased 7% to 426, and average daily sales through vending and in-plant customers rose 15% and 16%, respectively.
In Q&A, management added that automotive turned positive in June and that vending and in-plant sales per unit were up high single digits, reinforcing the argument that volume is improving underneath the pricing tailwind.
MSC Industrial Keeps the Q4 Bar FirmFor the fiscal fourth quarter, MSC Industrial guided to average daily sales growth of 6.5% to 8.5% and an adjusted operating margin of 10% to 10.8%. Clark said the outlook assumes a normal 40 to 50 basis point sequential gross margin decline and mid-20s adjusted incremental margin.
A D.A. Davidson analyst asked how much of the guide depends on pricing versus volume. Ryan Mills, head of investor relations, said price should run in the 6.5% to 7% range in the fiscal fourth quarter, implying volume improvement at the midpoint despite tougher comparisons.
A Stephens analyst also challenged whether the outlook assumes too much momentum after a strong June. Mills responded that the midpoint implies only a modest step-up versus June and said the company feels confident in the current demand and execution backdrop.
MSM Leaves a Constructive but Measured SignalBy the end of the call, management’s posture was clear: the restructuring phase is mostly complete, and the next phase is proving that improved sales execution and lower structural cost can produce sustained volume and margin gains. McIsaac sounded confident, but she did not overreach on the pace of that payoff.
MSM currently carries a Zacks Rank #2 (Buy), with a Value Score of C, Growth Score of B, Momentum Score of C and VGM Score of B. The rank remains the primary signal, while A and B Style Scores are the more favorable combinations, especially with a Zacks Rank #1 (Strong Buy) or #2. The current mix points to a constructive near-term profile, although the Zacks Rank can change as earnings estimate revisions shift after the quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
San Diego, California--(Newsfile Corp. - July 2, 2026) - Robbins Geller Rudman & Dowd LLP announces that the FS KKR class action lawsuit - captioned Stuart v. FS KKR Capital Corp., No. 26-cv-02969 (E.D. Pa.) - seeks to represent purchasers or acquirers of FS KKR Capital Corp. (NYSE: FSK) securities and charges FS KKR as well as certain of FS KKR's top executives with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the FS KKR class action lawsuit, please provide your information here:
You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected]. Lead plaintiff motions for the FS KKR class action lawsuit must be filed with the court no later than this Monday, July 6, 2026.
CASE ALLEGATIONS: FS KKR is a business development company specializing in investments in debt securities.
The FS KKR class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) FS KKR overstated the effectiveness of its portfolio restructuring efforts for its nonaccrual companies; (ii) FS KKR overstated the valuation of its portfolio investments and/or overstated the effectiveness of FS KKR's portfolio valuation process; and (iii) FS KKR overstated the durability of its quarterly distribution strategy.
The FS KKR class action lawsuit further alleges that on August 6, 2025, FS KKR reported second quarter 2025 earnings, revealing that FS KKR's net asset value had declined to $21.93 per share, down $1.44, or 6.2% from the prior quarter, and the total fair value of investments fell $474 million, to $13,648 million. Moreover, FS KKR allegedly reported a loss per share of negative $0.75, down $1.18 or 274.4% from the prior quarter, and a total net realized and unrealized loss per share of negative $1.36, down $1.12 or 466.7% from the prior quarter. Further, investments on non-accrual status allegedly rose to 3.0% and 5.3% of the total investment portfolio at fair value and amortized cost, respectively, compared to 2.1% and 3.5% in the prior quarter. On this news, the price of FS KKR stock fell more than 8%, according to the complaint.
Then, on February 25, 2026, FS KKR announced fourth quarter and full year 2025 earnings, allegedly revealing net asset value had continued to decline to $20.89, down $1.10 or 5% from the prior quarter, and the total fair value of investments fell another $406 million, to $13,009 million. Moreover, FS KKR allegedly reported a loss per share of negative $0.41, down $1.17 or 153.9% from the prior quarter, and a total net realized and unrealized loss per share of negative $0.89, down $1.08 or 568.421% from the prior quarter. Further, investments on non-accrual status again rose to 3.4% and 5.5% of the total investment portfolio at fair value and amortized cost, respectively, compared to 2.9% and 5.0% in the prior quarter. FS KKR also allegedly "acknowledge[d] specific challenges" with additional companies and cut its dividend to $0.48 per share (previously $0.70). On the accompanying earnings call, FS KKR's Chief Investment Officer, was allegedly forced to acknowledge that its "recent underperformance reflects challenges in certain legacy investments" in addition to those previously discussed, including Medallia and Cubic Corp. Further, challenges ran much deeper, as FS KKR revealed issues with the identified companies only accounted for "50% of net realized and unrealized losses." On this news, the price of FS KKR stock fell more than 15%, according to the FS KKR class action lawsuit.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired FS KKR securities during the class period to seek appointment as lead plaintiff in the FS KKR class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the FS KKR class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the FS KKR class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the FS KKR class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors - $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever - $7.2 billion - in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
Kontoor Brands is rated a buy due to an attractive post-Lee divestiture setup, with a clearer focus on Wrangler and Helly Hansen. Lee's sale for up to $1 billion provides KTB with significant financial flexibility for debt reduction and share repurchases. Wrangler delivers stable, cash-generating growth, while Helly Hansen offers higher-margin, premium outdoor/workwear expansion opportunities.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
IREN's Nasdaq-100 and Russell inclusion broadens institutional ownership as the investment case shifts from fundraising toward execution and revenue realization. Management revealed all operational AI capacity is fully contracted, while negotiations for 2027 deployments indicate execution has replaced demand as the bottleneck. Mirantis adds 650 engineers and over 1,500 enterprise relationships, strengthening IREN's vertically integrated AI cloud platform beyond infrastructure ownership alone.
Ademi LLP is investigating possible breach of fiduciary claims against Fiserv (NASDAQ: FISV). The investigation results from recent announcement, investigations and lawsuits against Fiserv.
Click here to join our investigation or to obtain additional information, or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
On June 15, 2026, Fiserv announced that its CEO and board member Michael P. Lyons was resigning effective immediately. The investigation focuses on whether the board of Fiserv has breached its fiduciary duties to shareholders.
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com
By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Paramount Skydance CEO David Ellison has leaned into technology since taking the helm. Ian Gavan/Getty Images for Paramount Pictures; Illustration by Cheng Xin/Getty Images Paramount Skydance has revamped another key tech team as CEO David Ellison's digital transformation takes shape.
Paramount's ad product and tech teams are joining forces, becoming the latest units to get a makeover. Earlier this year, Ellison combined streaming engineering groups and reassigned some staffers who'd helped merge the tech platforms of Paramount+ and free streamer Pluto TV.
Ad product and tech employees learned about the new structure and leaders in a late-June memo from Hugh Williams, a former Google tech exec who joined Paramount this spring as an EVP.
Merging the ad product and tech groups will help create "the modern, unified product and technology organization we set out to build," Williams said in the memo, which was obtained by Business Insider.
Ellison is set on modernizing Paramount, a 114-year-old Hollywood powerhouse that hasn't been known for its tech prowess. He's hoping to narrow the gap with Netflix, both by "prioritizing investments in advanced technology" and by buying Warner Bros. Discovery.
Paramount has made strides in streaming tech by adding a short-form video feed and plans to add interactive features, such as a shopping tool and sports stats. The company is also eyeing video podcasts to drive engagement.
Paramount's rearranged ad product and tech group has five parts, and each unit's leader will report directly to Williams, the EVP said.
Staffers on these teams should prepare for "movement between the groups soon to align with the new team structure," Williams added.
Todd Bender, currently Paramount's EVP of Advertising Platforms, will take on a new role as EVP of Integration, Williams said. Bender will support Williams and product chief Dane Glasgow "in complex integration planning work" with the changes, Williams said in the memo.
Here's a breakdown of Paramount ad product and tech's new structure and leadership team:Product Management (PM)Led by four executives:
Charlie Goodman: SVP, Decisioning & Ad Formats PMMatthew Jacobs: Senior Director, Reporting, Measurement, and Attribution PMGeorge Powell: VP, Ad Platforms & Systems PMMichele Stone: SVP, Revenue Enablement PMDescription: "Accountable for why we do work and what work we do, organized around the full 'pitch to pay' lifecycle of advertising across every screen. This spans how clients and our sales teams plan and transact with us; how we decide, deliver, operate, and shape the ad experience; the shared platforms and infrastructure the organization runs on; and how we measure outcomes and turn delivered value into revenue."EngineeringLed by Rich Orme: EVP, Engineering
Background: Orme joined Paramount in June after working in tech for close to three decades. He most recently started and ran AI advisory firm Leif Partners and previously worked at tech investment firm Silver Lake.Description: "Accountable for how and when we build software. Once the PM team decides what to build, Engineering owns the architecture, design, build, and delivery dates. Almost all of our engineers will report into this new organization."DataLed by TBD
Williams said that Paramount plans to hire an EVP of Data to head up its data science and analytics efforts.Description: "Accountable for how and when we build our data solutions, spanning analytics and data science. Analytics owns the insights, reporting, dashboards, experimentation, and ensuring our data is relevant, reliable, and reusable. They will answer the hard and interesting data questions about Ads. Data science owns the models and algorithms that power our products. Data partners closely with Engineering and is a key partner across Product Management."Advertising SolutionsLed by Dayna Wasilefski: VP, Advertising Solutions
Background: Wasilefski is a longtime Paramount executive stepping in for Paul Mahood, the ad sales product and tech SVP who's leaving the company at the end of July after more than two decades.Description: "Owns the significant vendor solutions that run our customer and linear businesses, including our CRM and all Salesforce instances, linear systems, and the technology behind local, sports, and our other non-streaming businesses. We will continue to deliver these with the availability and continuity the business depends on. This team owns the how and the when for customizing and operating those solutions."Field CTOLed by Travis Scoles: EVP, Field CTODescription: "A small, senior, client-facing team focused on direct relationships with our ad sales teams and advertisers. This team will build small, high-value custom solutions, representing our product and technology strategy to clients and partners, and feeding market intelligence back into the organization. Their work is deliberately one-off: anything that becomes durable is handed back to the broader organization to own and prioritize. The team will also represent Ads Product and Tech in client forums and evangelize Paramount as leaders in the Ads space."Paramount has a new-look leadership teamEllison's Paramount has had plenty of leadership changes this year.
Besides bringing on Williams, the company also landed former Google AI language product exec Barak Turovsky in May as its head of consumer AI. And in March, Paramount hired Danielle Carney from Amazon to oversee its US ad sales team.
Meanwhile, tech chief Phil Wiser left the company in late May. A few months earlier, agency partnerships EVP Chris Simon stepped down, and streaming product and tech chief Vibol Hou also left.
Read next
James Faris You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
A heavily hyped initial public offering (IPO). An impressive post-IPO pop. A subsequent pullback. Investors have seen this story play out before. And they're seeing it again with Space Exploration Technologies (SPCX 7.80%).
SpaceX delivered the biggest IPO in history. Its shares soared over the next few days following the IPO. Now, though, the stock is down roughly 22% below its peak. How long can SpaceX go? What comes next for the highly followed space technology company's shares? Here's what history suggests.
Image source: Getty Images.
The IPO stock playbook University of Florida finance professor Jay Ritter analyzed thousands of U.S. IPOs since 1980. He found that the average IPO stock jumped 19% on its first day of trading. Guess how big SpaceX's day one gain was? Pat yourself on the back if you answered 19%.
Whether or not an IPO stock soars initially, though, early pullbacks are also commonplace. That's especially the case for stocks that receive extensive media attention. For example, Tesla's (TSLA +1.20%) share price fell by more than 30% following its 2011 IPO. Meta Platforms (META +8.88%), then known as Facebook, lost more than half of its market cap in the first four months of trading.
Among the 15 largest U.S. IPOs since 2006, the average stock plunged around 50% below its IPO price at some point during the 12 months following the public listing. The average first-year returns for these stocks were roughly 33% losses.
But were long-term investors richly rewarded for being patient and waiting? Sometimes. Holding onto Tesla and Meta paid off tremendously for early investors. However, nine of the 15 largest U.S. IPO stocks have been losers for those who bought on the first day of trading. Rivian (RIVN 0.98%) is an especially instructive example, with its shares plunging more than 80% since the IPO.
Judging by the history of other major IPOs, the worst might not be over for SpaceX. Granted, the current rebound could continue for a while. However, SpaceX could decline by nearly 30% if it moves similarly to previous big IPO stocks.
One key tailwind for SpaceX, though, could be its upcoming inclusion in the Nasdaq-100 Index after the market close on July 6, 2026. All exchange-traded funds (ETFs) and mutual funds that track an index must own the index's underlying stocks.
On the other hand, SpaceX could also have a ticking time bomb on its hands. Following the company's second-quarter earnings report (likely in mid-August), 20% of eligible insider shares can be sold. This number will increase by 10% if the stock trades at least 30% higher than its IPO price during five of 10 consecutive trading days leading up to the Q2 update.
SpaceX also has other time-based IPO lockup period expirations. Insiders can sell up to 7% of shares at 70, 90, 105, 120, and 135 days following the IPO. After the Q3 earnings update, up to 28% more shares can be sold. Insider selling at high volumes would almost certainly create significant downward pressure on SpaceX's share price.
Math is more important than history. Mark Twain is often credited as saying, "History doesn't repeat itself, but it often rhymes." It's possible this adage could play out with SpaceX, with the stock plummeting as other high-profile IPO stocks have during their first year of trading.
However, SpaceX's market cap remains above $2.2 trillion. That's an astronomical valuation for a company that generated $18.7 billion in revenue last year. Sure, SpaceX is growing. But its growth isn't enough to justify the premium pricing at this point.
I think math is more important to SpaceX than history. Unfortunately, neither looks encouraging for investors considering buying the stock on the dip.
Space Exploration Technologies (SPCX 7.80%) delivered one of history's biggest stock market events just recently: the largest initial public offering ever. SpaceX, raising $75 billion in the operation, then saw its shares rise nearly 20% from the $135 offer price on its first day of trading. And the exercise of an overallotment option brought the total of funds raised to more than $85 billion.
Since that time -- the IPO was on June 12 -- all eyes have been on SpaceX stock. Investors may be intrigued by the offer itself, but also by the company's leader, Elon Musk, and his ambitious projects. Now, a new milestone lies right around the corner. SpaceX is set to join the Nasdaq-100, an index including the largest non-financial companies on the Nasdaq, on July 7.
Will SpaceX soar after that time? History offers a compellingly clear answer.
Image source: Getty Images.
An interesting mix of businesses First, let's consider why investors are so interested in SpaceX -- and this has to do with the company's interesting mix of growth businesses and its leadership. SpaceX is, as the name suggests, an expert in rocket launches. It aims to make launches cheaper and more efficient through its reusable technology -- and so far, it's made significant progress here. For example, NASA says that SpaceX's Falcon 9 back in 2010 reduced launch costs by a mind-boggling 85%. The goal now is to reduce costs by more than 99%, and a key step is just ahead: SpaceX aims to launch its fully reusable spacecraft, Starship, with payloads later this year.
SpaceX's second business is also closely linked to space: It's the satellite-based connectivity unit, Starlink, and is currently the company's biggest revenue driver. Last year, it brought in $11.4 billion on SpaceX's total of $18 billion. And Starlink membership, soaring from 2.3 million three years ago to more than 10 million today, offers us reason to be optimistic about growth.
Finally, SpaceX's third business is artificial intelligence (AI). Now, this might not seem space-related -- but it actually is. One of this unit's goals is to operate data centers in space, and the practical -- and cost-saving -- part of this is that SpaceX may use its own rockets to make this happen. And SpaceX also may use its rockets for the transport needs of Starlink.
Today's Change
(
-7.80
%) $
-13.32
Current Price
$
157.54
Elon Musk at the helm So SpaceX's businesses are diversified, yet they are complementary at the same time. And each may deliver a considerable amount of growth. Some investors also like the idea that Elon Musk is at the helm since he is known for being ambitious and innovative.
All of this is very positive, but it's also important to keep in mind that some of SpaceX's biggest goals involve technology that hasn't been fully developed or proven. And in order to develop that technology, SpaceX must invest billions of dollars. In fact, capital expenditures for its AI business last year reached $12 billion and helped push the company to a net loss. All of this represents risk. So even though SpaceX may be an exciting company, it's not the best investment for every investor, particularly at today's price.
At the current level, the stock trades at more than 100x sales, so it isn't cheap.
SPCX PS Ratio (Annual) data by YCharts
Entering the Nasdaq-100 Now, let's consider the upcoming Nasdaq-100 entry. This is due to the new "fast track" procedure that offers companies admission after only 15 trading days -- as long as they are among the 40 biggest in the index in terms of market value. SpaceX makes the cut and will join as of July 7. This means that funds tracking the Nasdaq-100 must add SpaceX shares, and this buying activity may lift the stock.
But this doesn't necessarily mean the stock will soar, as history shows us. A look at recent Nasdaq-100 additions -- added June 22 of this year -- didn't result in significant gains for those players.
ALAB data by YCharts
A look back farther in time, to 2024, when Palantir Technologies, Strategy, and Axon Enterprise joined the Nasdaq-100, shows all three actually declined in the 10 days to follow.
PLTR data by YCharts
So, while SpaceX could see a slight pop, as funds scoop up the shares, significant positive movement isn't guaranteed. What does this mean for you? In any case, short-term stock movements shouldn't be a concern. When investing, it's crucial to hold onto stocks for the long term, at least five years, to truly benefit from the company's growth. So, you shouldn't worry about buying SpaceX before a particular event, such as this Nasdaq-100 entry.
Instead, it's a better idea to take your time and consider the company's upcoming earnings reports before deciding whether to get in on this exciting but risky stock.
Apple plans to launch at least five new iPhone models between the second half of this year and the first half of 2027, while increasing production plans for foldable devices, as it looks to vie for a greater slice of the market amid an industrywide component supply shortage, Nikkei Asia reported Thursday.
The U.S. tech giant has instructed suppliers to prepare to produce about 10 million foldable iPhones this year, up from an earlier forecast of 7 million to 8 million units, the report said, citing people familiar with the matter.
Ahead of launching its first-ever foldable device, Apple has already secured components for about 80 million smartphones spread across new models for the second half of 2026, according to Nikkei Asia.
Apple's total smartphone production for 2026 is expected to exceed 220 million units, the report said. Its scale and purchasing power in sourcing memory and components remain significantly stronger than most of its peers, even as shortages driven by AI-related demand ripple through the industry.
This has allowed Apple to navigate supply shortages better than Chinese rivals such as Xiaomi, Oppo, and Vivo, which have each slashed their annual production targets to below 100 million units, Nikkei Asia reported.
"Compared with Apple's bargaining power, the Chinese smartphone makers are in a weak spot in terms of getting more supplies of memory chips or increasing the prices," an executive at a supplier for both Apple and Xiaomi told Nikkei Asia. "It gives Apple a good motivation to launch the iPhones in spring and take more of their share."
Apple's efforts to secure components come as a global memory shortage driven by demand from artificial intelligence data centers pushes up costs across the industry.
Bloomberg reported Thursday that Apple is in talks to source memory chips for devices sold in China from Chinese manufacturers ChangXin Memory Technologies and Yangtze Memory Technologies, both of which are included on a Pentagon list of companies alleged to support Beijing's military. Apple has not confirmed the discussions, and Bloomberg reported that negotiations remain ongoing.
Apple is reportedly seeking to broaden its supplier base as memory shortages strain production across the consumer electronics sector.
Apple plans to introduce at least two new iPhones in the first half of 2027, including the standard iPhone 18 and a new iPhone Air, according to Nikkei Asia.
The aggressive product roadmap comes after Apple implemented price hikes for its MacBook and iPad lineups last week as memory and storage costs surged.
Apple did not immediately respond to CNBC's request for comment.
Apple stock NASDAQ:AAPL remained in focus on Thursday after reports of an expanded iPhone launch cycle, setting up a familiar split screen for investors: a powerful company, but a stock that no longer looks cheap.
The catalyst was a Nikkei Asia report that Apple is preparing at least five new iPhone models across the second half of 2026 and the first half of 2027.
The timing matters because the plan lands just as an AI-led memory shortage is raising costs across the consumer electronics supply chain.
Apple is planning one of its most ambitious iPhone cycles in years.
Nikkei Asia reported that the company wants to launch at least five new models through early 2027, while also lifting its foldable iPhone production target to about 10 million units this year, up from an earlier forecast of 7 million to 8 million.
That would put Apple directly into a foldable market already contested by Samsung and Huawei.
For bulls, the timing could be powerful. Morgan Stanley analysts have said Apple has a path to more than 250 million iPhone shipments in FY27, helped by stronger upgrade rates and the first foldable iPhone.
Their bull case values the stock at $376 if foldables and AI drive stronger demand.
The bear case is that investors may be getting ahead of the market.
Jefferies recently downgraded Apple to Underperform, warning that expectations around upcoming iPhone models and the upgrade cycle had become unrealistic.
The bigger problem is not whether Apple can build excitement, but whether it can protect margins while doing so.
The AI data-centre boom has tightened the supply of DRAM and NAND chips, the same memory components used in phones, tablets and laptops.
As per JPMorgan data, memory could account for about 45% of iPhone production costs by 2027.
That leaves Apple with an awkward choice. It can absorb higher component costs and pressure margins, or pass more of those costs to consumers and risk slowing upgrades.
That tension was already visible in June, when Apple raised prices on Macs, iPads and other products because of memory costs.
The investor reaction was immediate as Apple stock fell 6.12% to $275.15 on June 25 after the price-hike news.
Wall Street is split between product-cycle optimism and valuation discipline.
KGI Securities downgraded Apple to Hold from Outperform with a $315 price target, signalling limited upside after the stock’s strong run.
Others remain more constructive. TD Cowen raised its Apple target to $350 from $335 and kept a Buy rating.
Maxim Group also raised its target to $350 from $310, with analyst Tom Forte saying Apple’s WWDC presentation showed “meaningful improvements” in its AI efforts and could support both services and hardware sales.
U.S. social media giant Meta Platforms has defended the rollout of usernames on its messaging platform, after the Indian government on Wednesday said the move could lead to a rise in cybercrime.
"Users still require a phone number to use WhatsApp, and we've built multiple layers of defense against scams into usernames," a Meta spokesperson told CNBC in an email.
The tech company said it will limit the number of new people an account can contact, block repeated attempts to guess usernames, and enable systems to detect and remove activity demonstrating common patterns associated with impersonation or abuse.
It added that the username feature is not live and will be rolled out "slowly later this year." On Monday, WhatsApp introduced usernames, claiming it to be a "major privacy feature" designed to help people stay connected without giving away phone numbers.
According to a report by Indian news agency ANI, the Indian government said that the username feature "may materially increase the incidence of online fraud, phishing, digital arrest scams and impersonation attacks, by enabling bad actors to solicit and message victims."
It has given WhatsApp three days to furnish a detailed explanation on the feature or face action under the country's information technology regulations. The company has been directed to pause the rollout of the feature until the government's concerns are addressed.
Safety over privacyWhile user privacy does play a role in policymaking, the "sharp rise in cyber-enabled financial crime has undoubtedly shifted the center of gravity towards security," Reema Bhattacharya, head of Asia research at Verisk Maplecroft, told CNBC.
Meta's own Adversarial Threat report in March found that online scam syndicates targeted users in India more frequently than any country other than the U.S. According to the Indian government, cybercrime incidents more than doubled in 2024 to nearly 2.3 million cases from 1 million cases in 2022.
India has more than half a billion WhatsApp users, and this scale makes it prone to government scrutiny, experts said.
WhatApp's reach, coupled with the username feature, means "misinformation could spread even faster," and scammers could use familiar names and photos to impersonate people, said Neil Shah, vice president of research at Counterpoint Research.
Some of these concerns are being addressed by Meta. The company told CNBC that it would reserve the highest-profile names, which can only be claimed by their legitimate owners, and withhold lookalike derivatives of known names to protect against impersonation.
Governments increasingly expect digital platforms to share responsibility for reducing harm, Bhattacharya said, but added that it is difficult "to draw the line between legitimate regulation and measures that could discourage innovation or weaken user privacy."
The government oversight of WhatsApp's username feature comes just weeks after India temporarily banned Telegram to prevent exam fraud during a crucial national test.
The government said that the platform hosted several channels that made false claims to have leaked test papers and then demanded money from candidates and their families for access. Telegram responded that the move punished "150 million ordinary users of the app" in India, and not those who leaked the exam material.
India has asked Meta to hold off launching its username feature on WhatsApp in the world's most populous country, citing concerns over fraud and impersonation, media reports said Thursday.
Tesla Model 3 vehicles are shown for sale at a Tesla facility in Long Beach, California, U.S., May 22, 2023. REUTERS/Mike Blake Purchase Licensing Rights, opens new tab
CompaniesJuly 2 (Reuters) - The U.S. National Highway Traffic Safety Administration (NHTSA) on Thursday said it had closed its 2022 preliminary evaluation into 695,000 Tesla (TSLA.O), opens new tab vehicles over unexpected deceleration, citing low demonstrated hazard to drivers and a substantial drop in incidents.
Here are a few details:
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
The investigation covered Model 3 and Model Y vehicles.
NHTSA said that Tesla had released software updates in early 2022 to target unexpected deceleration.
Incident reports declined to 45 in 2024, 19 in 2025, and three since the start of 2026, according to the auto safety regulator. There were 300 such reports when the investigation was opened.
The regulator said the reported conditions did not alter the vehicle’s lateral positioning in their lanes and did not cause significant loss in distance between the subject and following vehicle to lead to a collision.
Last week, NHTSA had separately closed an expanded probe covering an estimated 376,241 Model 3 and Model Y vehicles over loss of steering control.
Reporting by Disha Mishra in Bengaluru; Editing by Nivedita Bhattacharjee
Our Standards: The Thomson Reuters Trust Principles., opens new tab
A Google logo is seen at a company research facility in Mountain View, California, U.S., May 13, 2025. REUTERS/Carlos Barria/File Photo Purchase Licensing Rights, opens new tab
CompaniesBRUSSELS, July 2 (Reuters) - Alphabet's (GOOGL.O), opens new tab Google on Thursday lost its fight against a record fine imposed by EU antitrust regulators eight years ago for using its Android mobile operating system to block rivals, a court ruling likely to boost Europe's crackdown on Big Tech.
The European Commission had originally handed out a €4.34 billion fine to Google in 2018 for its agreements which forced phone manufacturers to pre-install Google Search, the Chrome browser and the Google Play app store on their Android devices and prevented them from using rival Android systems.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
A lower tribunal subsequently trimmed the fine to €4.1 billion in 2022 after the world's most popular search engine challenged the EU penalty. Google then appealed to the Luxembourg-based Court of Justice of the European Union, Europe's highest.
The court sided with the EU antitrust enforcer.
"The appeal brought by Google and its parent company Alphabet against the judgment of the General Court is dismissed, thereby confirming the penalty imposed for Google Search's abuse of a dominant position in the context of the Android operating system," judges said.
A Google spokesperson said that the judgment failed to take into account its investment to ensure Android remains open, interoperable and free.
"In any event, we adapted our agreements to comply with the initial decision back in 2018 and we remain focused on continued innovation and openness for our users, partners and developers", Google said.
Google has racked up close to €11 billion in EU fines in the last decades for various antitrust infringements.
It will likely see more fines in the near future for allegedly favouring its own services and products in search results and for practices related to its app store, both of which fall under the Digital Markets Act aimed at reining in the power of Big Tech.
The case is C-738/22 P Google and Alphabet v Commission.
Reporting by Foo Yun Chee and Sudip Kar-Gupta; Editing by Louise Heavens
Our Standards: The Thomson Reuters Trust Principles., opens new tab
An agenda-setting and market-moving journalist, Foo Yun Chee is a 21-year veteran at Reuters. Her stories on high profile mergers have pushed up the European telecoms index, lifted companies' shares and helped investors decide on their next move. Her knowledge and experience of European antitrust laws and developments helped her break stories on Microsoft, Google, Amazon, Meta and Apple, numerous market-moving mergers and antitrust investigations. She has previously reported on Greek politics and companies, when Greece's entry into the eurozone meant it punched above its weight on the international stage, as well as on Dutch corporate giants and the quirks of Dutch society and culture that never fail to charm readers.
Europe's top court on Thursday upheld Google's fine of around 4.1 billion euros ($4.67 billion) over alleged anti-competitive practices.
In 2018, the European Commission slapped Google with the record-breaking penalty on the grounds that it abused Android's mobile dominance to give unfair advantage to its own apps via pre-installation deals with smartphone makers.
Google has been appealing the ruling through the EU court system. But the European Court of Justice (ECJ), Europe's top court, dismissed Google's appeal.
"The Court of Justice dismisses the appeal brought by Google and Alphabet against that judgment of the General Court, thereby confirming the penalty imposed on them, as revised by the General Court, for their anticompetitive practices relating to the Android operating system," the ECJ said in a press release.
CNBC has reached out to Google for comment.
In 2022, a lower EU court reduced the fine to the current 4.1 billion euros from 4.34 billion euros previously.
Google has argued that the Android operating system provides choice for users and supports developers and businesses across Europe.
"Android provides more choice for everyone and supports thousands of businesses. This judgment fails to recognize our significant investment to ensure Android remains open, interoperable and free," a Google spokesperson told CNBC.
"In any event, we adapted our agreements to comply with the initial decision back in 2018 and we remain focused on continued innovation and openness for our users, partners and developers."
Google has attempted to allay the Commission's concerns over the years such as allowing Android users to switch between search engines and browsers so they are not tied to the company's apps.
EU's Big Tech crackdownThe European Commission, the EU's executive arm, has been pursuing Google for more than a decade after first opening proceedings against the company in 2015.
Google has been in the crosshairs of the Commission over several alleged antitrust practices. Last year, the Commission hit Google with a 2.95 billion euro fine for anti-competitive practices in its advertising technology business.
While antitrust is still a focus for the Commission, the regulator is now looking at the practices of big technology firms under the sweeping Digital Markets Act, with companies like Apple and Meta also under scrutiny.
Europe's treatment of U.S. technology companies has drawn the ire of President Donald Trump and other U.S. officials. Last month, Trump threatened to impose a "100% TARIFF" on goods of any country that imposes a digital services tax on U.S. Companies. European countries such as France and Spain have imposed a digital services tax.
In March, the U.S. ambassador to the EU Andrew Puzder told CNBC that Europe "can't over regulate" and hit companies with "huge fines" if it is going to participate in the AI economy.
The EU's top court will decide Thursday whether to uphold a record 4.1 billion euro ($4.7 billion) fine the bloc slapped on Google for anticompetitive practices related to its Android operating system.
In 2018, the European Commission imposed the fine on Google for abusing Android's dominance in the industry. Photo: josh edelson/Agence France-Presse/Getty ImagesAlphabet on Thursday lost its appeal against an antitrust fine imposed on the tech giant by a top European court.
The Court of Justice of the European Union has ruled to uphold a record €4.1 billion ($4.68 billion) fine over alleged anti-competition practices.
About the Author
Nora Redmond is a MarketWatch reporter based in London.
SummaryMicrosoft's RPO surged 99% year over year to $627 billion, with approximately $157 billion expected to convert into revenue within 12 months.AI monetization extends beyond inference, driving strong growth across Cosmos DB, OneLake, Azure infrastructure, storage, compliance, and enterprise data services.AI ARR reached $37 billion, up 123% year over year, while Azure is guided to deliver approximately 40% constant-currency growth next quarter.Microsoft's multi-model AI strategy and Maia/Cobalt silicon should reduce inference costs, supporting long-term margin expansion despite elevated infrastructure investments.Risks include a projected $190 billion FY26 CapEx program, declining cloud gross margins, regulatory scrutiny, and increasing competition following OpenAI's reduced exclusivity. tupungato/iStock Editorial via Getty Images
Investment Thesis Microsoft's (MSFT) narrative has changed dramatically over the last few quarters. The question now is not whether Microsoft can monetize AI but how much monetization has been locked in already. MSFT is
17.13K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in MSFT over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
JPMorgan Chase & Co. (NYSE:JPM) will release earnings for its second quarter before the opening bell on Tuesday, July 14.
Analysts expect the New York-based company to report quarterly earnings of $5.61 per share, up from $4.96 per share in the year-ago period. The consensus estimate for JPMorgan’s quarterly revenue is $49.56 billion. It reported $44.91 billion last year, according to Benzinga Pro.
JPMorgan stated on Monday that it supports a regulatory framework for cryptocurrencies but warned the rules could carry risks, especially for stablecoins and yield-producing products.
Shares of JPMorgan rose 2.1% to close at $334.07 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
Considering buying JPM stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Verizon was just dropped from the Dow Jones Industrial Average and replaced by Alphabet. Verizon has raised its dividend for 19 straight years, one of the longest streaks in telecom.
Chevron's valuation looks attractive, especially in light of its growth prospects. Buying the stock allows investors to begin receiving Chevron's juicy dividends sooner rather than later.
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2026) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that Phase II drilling at the Copper Mountain Uranium Project in Wyoming has commenced.
Highlights
Phase II drilling is now underway at the Copper Mountain Uranium Project in Wyoming. The first four holes will test mineralization at Lucky Cliff, a high-priority target area drilled by Union Pacific in the late 1970s and never followed up with modern techniques (see Figure 3).
Any mineralization confirmed at Lucky Cliff will be outside the 1982 U.S. DOE Bendix Engineering Report "Assessment Area" ("the Bendix Report") previously reported here (see Figure 1).
Once the holes at Lucky Cliff are complete, the Phase II program will turn to drilling areas, other than Canning, that are associated with historical resource estimates totalling 26.63 Mlbs eU3O8 contained in 44.1 Mt at an average grade of 171 ppm eU3O8, which are not being treated as current mineral resources or mineral reserves (see note about Historical Estimates below).
Canning contains roughly half of the historically estimated resources at Copper Mountain and was the focus of Myriad's highly successful 34-hole Phase I drill program in late 2024 (release here).
Phase II will also test new targets identified by our recent geophysics (release here), which have undergone verification by ground truthing using a hand-held gamma spectrometer.
The final stage of Phase II will be infill drilling to support a current mineral resource estimate under NI 43-101.
In 1982, Bendix Engineering for the U.S. Dept. of Energy reported an exploration target for Copper Mountain of 245 to 655 Mlbs eU3O8 contained within 1,111 Mt to 2,971 Mt (at 100 ppm eU3O8) and 222 Mt to 594 Mt (at 500 ppm eU3O8). Reported here and here (see Figure 1 and details below).
The potential tonnages and grades of the Bendix exploration target are conceptual in nature and are based on previous drill results and there has been insufficient exploration to define a current mineral resource, and it is uncertain if further exploration will result in the target being delineated as a mineral resource. See the section titled "Copper Mountain Exploration Target" below for more details.
Myriad's CEO, Thomas Lamb, commented: "Our aim for Phase II drilling will be to confirm mineralization, not just at the historically estimated areas of Copper Mountain, but also at entirely new targets identified through our successful geophysics programs and subsequent ground truthing. We also hope that Phase II, once complete, will provide support for a compelling current mineral resource estimate."
Mr. Lamb continued: "Beyond Phase II drilling, Myriad has a fast-moving and exciting 12 months ahead.
Our merger with Rush is in the final steps of completion and will consolidate 100% ownership of Copper Mountain. This will have many benefits, including increasing our market cap, attracting institutional investor interest, simplifying operational decision-making, and broadening access to financing.We plan to uplist to a major U.S. exchange.8VC-backed Subatomic will be advancing the Red Basin, NM project, in which we hold a 10% free carried interest (release here). Exploration of our Breccia Pipe Project in Arizona, which includes the Wate Pipe's high grade historical resource estimate, will commence (release here)."
Figure 1: Target positions relative to the Bendix Assessment area.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6301/303712_caea8a6de484c9fa_002full.jpg
Nasco Industrial Services and Supply (NISS) has deployed a Boart Longyear LF90D surface diamond core drill rig to Copper Mountain. The LF90D is a powerful, highly mobile surface diamond core drill rig known for its deep coring capacity and reliable hydraulic systems. It features a telescopic mast designed for both 3-metre (10 ft) and 6-metre (20 ft) rod pulls (Figure 2).
Figure 2: The Boart Longyear LF90D surface diamond core drill rig tramming to the project area at Copper Mountain.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6301/303712_caea8a6de484c9fa_003full.jpg
Lucky Cliff
Lucky Cliff is located about 2000 metres (6,500 feet) north of the Canning deposit, along the Myrtle's Fault trend. The target area was selected by Union Pacific as a drill target on the basis of favourable geological and geochemical criteria. Several strong N45°E structural trends are present, and the associated rock types are similar to those found at other mineralized occurrences in the project area. A close-spaced (500-foot center) stream sediment sampling program undertaken by Union Pacific identified several highly anomalous (to 118 ppm) zones, and follow-up work was designed to test these anomalies. Ground-truthing of radiometric anomalies by Myriad following the helicopter survey completed late last year identified one point above the target area with a surface measurement of 193.2 ppm eU, using a calibrated RS-230 Handheld Gamma-Ray Spectrometer. Handheld spectrometer readings are preliminary and indicative only, may be affected by environmental and geometric factors, are not assay results and may not be representative of uranium concentrations in rock samples.
At least twenty holes were drilled by Union Pacific in the late 1970s. At least 10 holes intersected mineralisation in excess of 100 ppm eU3O8 from depths as shallow as 20 ft (6 m). LK-9 intersected 355 ft of 0.027% eU3O8 starting at 59 ft (including 207 ft of 0.032% eU3O8). LK-11 intersected 31 ft of 0.020% at 21.5 ft and 59.5 ft of 0.025% at 83.5 ft. Other intersections in this target area included 15.5 ft of 0.055% eU3O8 at 55 ft in hole LK-10. Higher grades are associated with a mafic dyke intruding the main fault zone through the target area. There is no historic resource estimate for Lucky Cliff. Reported widths are historical downhole widths and true widths are unknown. Equivalent ("e") uranium grades were determined by AEC gamma probes using appropriate calibration factors. No original assay certificates or complete QAQC records have been reviewed by the Company or the Qualified Person for these historical drill results.
Figure 3: Planned drilling at Lucky Cliff. The purple shaded areas represent anomalous surface uranium measurements from Myriad's recent helicopter radiometric survey.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6301/303712_caea8a6de484c9fa_004full.jpg
Copper Mountain Exploration Target
In 1982, Bendix Field Engineering Corp. ("Bendix") identified an exploration target of 245 to 655 Mlbs eU3O8 contained within 1,111 Mt to 2,971 Mt (at 100 ppm eU3O8) and 222 Mt to 594 Mt (at 500 ppm eU3O8). This was based on previous exploration on the property by Union Pacific Corp. and Bendix own work, including data from over 1,370 historic drill holes. The exploration target and methodology were detailed in two reports by Bendix titled "An Exploration Systems Approach to the Copper Mountain Area Uranium Deposits, Central Wyoming (September 1982)" and "Copper Fountain, Wyoming, Intermediate-Grade Uranium Resource Assessment Project Final Report (September 1982)", respectively. The exploration target potential was derived from geologic reconnaissance and geochemical, geophysical, petrologic, borehole, and structural data interpretations that were used to develop a genetic model for uranium mineralization in these environments. Development of a structural scoring system and application of models in a high-confidence control area established the basis for estimations of the uranium target in the total assessment area covering approximately 39.6 square miles. The volume of the modeled areas determines the potential tonnage statement in the exploration target. The grade range given in the exploration target is determined with consideration to the drill results within the modeled exploration target area and consideration of the geological setting in an established exploration camp. The potential tonnages and grades are conceptual in nature and are based on previous drill results that defined the approximate length, thickness, depth and grade of the portion of the historic mineral resource estimate. There has been insufficient exploration to define a current mineral resource, and it is uncertain if further exploration will result in the target being delineated as a mineral resource. Further details are available in the current NI 43-101 Technical Report.
Historical Resource Estimates
The historically estimated resources totalling 26.6 Mlbs eU3O8 contained in 44.1 Mt at an average grade of 171 ppm eU3O8 (using 100 ppm cut-off) were compiled from internal progress reports produced by Union Pacific subsidiary, Rocky Mountain Energy Company. In particular, a report titled "Copper Mountain Exploration Project Report" prepared by Southard, G.G., et. al., (1979) for Rocky Mountain Energy Company. The estimates were completed using polygonal methods based on modelled mineralization geometries. The historic resources were classified as Inferred and Indicated using U.S. Bureau of Mines categories at the time and do not necessarily correspond with the resource categories defined by current NI 43-101 definitions and guidelines. Details of the historical resource estimates are available in the current NI 43-101 Technical Report.
While Myriad Uranium has determined that the historical estimates described in this news release are relevant to the Copper Mountain Project Area and are reasonably reliable given the authors and circumstances of their preparation, and are suitable for public disclosure, readers are cautioned to not place undue reliance on these historical estimates as an indicator of current mineral resources or mineral reserves at the Project Area. A qualified person (as defined under NI 43-101) has not done sufficient work to classify any of the historical estimates as current mineral resources or mineral reserves, and Myriad Uranium is not treating the historical estimates as a current mineral resource or mineral reserve. Also, while the Copper Mountain Project Area contains all or most of each deposit referred to, some of the resources referred to may be located outside the current Copper Mountain Project Area. Furthermore, the estimates are decades old and based on drilling data for which the logs are, as of yet, predominantly unavailable. The historical resource estimates, therefore, should not be unduly relied upon.
Inherent limitations of the historical estimates include that the nature of mineralization (fracture hosted) makes estimation from drill data less reliable than other deposit types (e.g. those that are thick and uniform). From Myriad Uranium's viewpoint, limitations include that the Company has not been able to verify the original data itself and that the estimates may be optimistic relative to subsequent work which applied a "delayed fission neutron" (DFN) factor to calculate grades. On the other hand, DFN is controversial, in that the approach is viewed by some experts as too conservative. Nevertheless, it was applied in later resource estimations by Union Pacific relating to Copper Mountain. To verify the historical estimates and re-state them as current resources, a program of re-drilling is required to generate new data that can be used to establish the correlation and continuity of geology and grades between boreholes with sufficient confidence to estimate mineral resources.
Qualified Person
The scientific and technical information in this news release has been reviewed and approved by George van der Walt, MSc., Pr.Sci.Nat., FGSSA, a "Qualified Person" as defined under NI 43-101. Mr. van der Walt is a Principal Consultant with The MSA Group (Pty) Ltd, an independent consultancy. A Qualified Person has not done sufficient work to verify historic exploration results or to classify the historical estimates referred to in this news release as current mineral resources or mineral reserves, and Myriad is not treating such historical estimates as current mineral resources or mineral reserves.
About Myriad Uranium Corp.
Myriad Uranium Corp. holds a 75% interest in the Copper Mountain Uranium Project in Wyoming, USA, with a definitive agreement in place to acquire the remaining 25% via the acquisition of Rush Rare Metals Corp. Copper Mountain hosts multiple historic uranium deposits and past-producing mines, including the Arrowhead Mine (approximately 500,000 lbs U₃O₈ produced). Union Pacific conducted extensive exploration and development in the district during the late 1970s, including approximately 2,000 boreholes and advanced mine planning, before the uranium market downturn in 1980. Union Pacific is estimated to have invested approximately C$125 million (2026 dollars) in the project, generating significant historical resource estimates.
A news release detailing a comprehensive assessment of Copper Mountain's uranium endowment by Bendix Engineering for the US Department of Energy published in 1982 can be viewed here.
Myriad holds a 10% free carried interest in the Red Basin Uranium Project, recently sold to 8VC- and Overmatch-backed Subatomic Industries. Red Basin carries significant historical resource estimates from extensive drilling by Occidental Oil in the late 1970s, and also hosts vanadium, which has been designated a strategic and critical mineral by the U.S. government. Note the caution on historical estimates below.
Myriad's 100%-owned Breccia Pipe Project in Arizona comprises at least 23 breccia pipes that are prospective for uranium and REEs. One of the pipes, the Wate Pipe, was previously owned and explored by Energy Fuels and is the subject of a historical resource estimate. The Breccia Pipe Project has been optioned to Wedgemount Resources (release here).
Note: A qualified person has not done sufficient work to classify the Copper Mountain, Red Basin, and Breccia Pipe Project historical estimates as current mineral resources or reserves and Myriad is not treating historical estimates as current resources or reserves. Myriad intends to conduct further work to determine whether the historical estimates can be verified and, if appropriate, supported by current mineral resource estimates.
Forward-Looking Statements
This news release contains "forward-looking information" that is based on the Company's current expectations, estimates, forecasts and projections. This forward-looking information includes, among other things, the Company's business, plans, outlook and business strategy. The words "may", "would", "could", "should", "will", "likely", "expect", "anticipate", "intend", "estimate", "plan", "forecast", "project" and "believe" or other similar words and phrases are intended to identify forward-looking information. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect, including with respect to the Company's business plans respecting the exploration and development of the Company's mineral properties, the proposed work program on the Company's mineral properties and the potential and economic viability of the Company's mineral properties. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the Company's actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Such factors include, but are not limited to: inability to verify historical data, no assurance of defining mineral resources, permitting, drilling delays and changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the contents of this news release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/303712
Source: Myriad Uranium Corp.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Costco (COST 1.23%) and Amazon (AMZN +1.48%) both have been winners for investors in recent years. The companies have strong track records of earnings growth, a loyal customer base, and strong competitive advantages. This has helped each of these stocks gain about 80% over the past three years.
So Costco and Amazon each represent fantastic long-term investments, ones you will want to keep in your portfolio for at least five to 10 years. These are true growth stock superstars. But what if you could only invest in one of them right now? Which of the two is the better buy? Let's find out.
Image source: Getty Images.
The case for Costco You probably have seen a Costco in or near your community, as the retailer has more than 900 warehouses worldwide. Most of them are in the U.S. and Canada, the company's biggest markets.
One of the things I like most about Costco is its business model: The retailer generates revenue from you before you even start your shopping. This is through membership fees, which actually drive the company's profit -- that's because membership is a high-margin business, involving very low costs for Costco. Importantly, membership renewals in the U.S. and Canada have surpassed 90% consistently quarter after quarter. So this is revenue -- and eventually profit -- that you can count on.
Today's Change
(
-1.23
%) $
-11.54
Current Price
$
923.93
Costco is also generally a winner in any market environment since the company focuses on delivering rock-bottom prices to customers -- and its strong sourcing network to deliver these prices is a clear competitive advantage.
As a result, even during economic downturns, customers may continue shopping more at Costco than at other retailers. It's also important to note that Costco offers essentials like food and gas that keep customers coming back, even if their wallets are under pressure.
The case for Amazon Amazon is another retailer that's keenly focused on offering customers low prices -- and that's prompted them to return. The company's worldwide e-commerce presence and Prime membership program represent strong competitive advantages that rivals would find hard to replicate. Prime offers customers advantages like fast delivery and access not only to shopping but also to entertainment, such as books and movies.
Today's Change
(
1.48
%) $
3.52
Current Price
$
241.87
Like Costco, Amazon has what it takes to excel throughout economic environments, and the company's broad fulfillment network is yet another competitive strength. In recent years, Amazon took steps to improve its cost structure -- for example, shifting to a regional fulfillment model in the U.S. from a national one -- and this should support earnings growth in the years to come.
Amazon is also winning in the artificial intelligence (AI) boom. The company uses AI to gain efficiency, and it's a developer and seller of AI products and services through its Amazon Web Services (AWS) cloud computing business. This presence in AI has driven growth in recent years and is likely to drive more in the years to come, since we're in the early days of the AI growth story.
As mentioned, both of these stocks make great additions to a portfolio. Costco trades at a premium, as it generally does -- but in recent times, valuation has come down. Amazon also has seen its valuation decline in recent weeks. Today, both are trading at reasonable levels.
AMZN PE Ratio (Forward) data by YCharts
Which is the better buy? This depends on your investment strategy. If you're an investor who favors growth and doesn't mind some risk, you may pick up a few shares of Amazon. I think Amazon's long-term future is bright, and it's demonstrated its revenue power in the AI market. But in recent weeks, concerns about the sustainability of tech spending on AI have weighed on AI stocks -- if this pressure continues, the stock may slip in the near term.
Meanwhile, Costco, in an uncertain environment, may offer you more stability. And that's why, in this growth showdown, Costco stock is the better buy for most investors.
Finding good dividend stocks isn't too tall a task. Finding dividend stocks you can feel good about buying and holding forever, however, is a different story. The world is constantly changing. Companies that are firing on all cylinders today may be irrelevant tomorrow.
But there are some businesses that are just built to last, and to pay a reliable dividend as long as they do. Realty Income (O 0.12%) is one of those businesses.
Image source: Getty Images.
Built tough It's not exactly a household name, although it's likely that you or someone in your household regularly steps into one of its properties. Realty Income is a real estate investment trust (REIT), and as such, it owns a portfolio of commercial real estate that it rents to other companies. Realty Income's specialty is brick-and-mortar retailing.
At first blush, this seems risky. The so-called retail apocalypse is still underway, after all. Realty Income is largely defying it, though. With top-20 tenants like Dollar General, FedEx, Home Depot, and Walmart, this REIT is reliably able to maintain occupancy rates in excess of 98%. Even during pandemic-riddled 2020, its full-year occupancy only slipped to 97.9%.
Today's Change
(
-0.12
%) $
-0.07
Current Price
$
61.88
This resiliency is translating into ultra-reliable monthly dividends and dividend growth for shareholders. Not only has the company paid a monthly dividend like clockwork since its founding in 1969, but it has also raised its per-share payout every quarter since 1998.
And by more than a little. Over the past 10 years, its monthly payment has improved from $0.2115 per share to $0.2710. This dividend growth paired with the stock's capital appreciation has produced a compound average annual return of 13.6% since Realty Income was listed on the New York Stock Exchange in 1994.
Willing and able to adapt, too It's possible that the traditional brick-and-mortar retailing sector could continue deteriorating under the weight of e-commerce's proliferation, to the point where even rock-solid Realty Income starts to struggle. Meanwhile, higher interest rates are a temporary headwind.
But while that's possible, it's not likely. There's plenty of consumer-facing retailing that will never quite work online, and to the extent online shopping poses a threat to the business, many of Realty Income's tenants like Walmart also have e-commerce operations to go with their brick-and-mortar segments. Or they are businesses like FedEx that benefit from online shopping's continued growth.
Even so, concerned investors should know that Realty Income's management is testing the waters of other markets, including artificial intelligence (AI) infrastructure by partnering with AI data center owner/operator Digital Realty on new facilities. While this isn't a significant business yet, Realty Income's willingness to entertain obvious opportunities is encouraging.
Even more encouraging is that Realty Income doesn't need to rush into these new markets. It can take its time, since its well-established retailing portfolio remains a reliable cash cow. This sort of well-managed flexibility ultimately translates into longevity.
James Brumley has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Digital Realty Trust, Home Depot, Realty Income, and Walmart. The Motley Fool recommends FedEx. The Motley Fool has a disclosure policy.
There's no denying the potential for artificial intelligence (AI) to alter the technology landscape in ways that we don't yet comprehend. These sophisticated algorithms are being used to automate tasks, analyze data, and even write computer code -- all of which promise to make businesses more efficient. Unfortunately, there's no consensus on the best way to implement AI, particularly for managers seeking the best return on their investment.
Investors are equally divided. On one side of the argument are those concerned that rising valuations of some AI stocks will hamper future returns, while the other camp argues that exceptional returns should command premium valuations.
One company that epitomizes this tug-of-war is Palantir Technologies (PLTR +7.84%). The company has emerged as one of the leading providers of AI systems that extract siloed information, delivering data-informed solutions to company-specific business problems.
One analyst has just crunched the numbers and concluded that Palantir is undervalued.
Image source: Getty Images.
Context is key The popular narrative is that Palantir is overvalued, and it's easy to understand why. The stock has a price-to-earnings (P/E) ratio of 131. For comparison, the S&P 500 (SNPINDEX: ^GSPC) has a multiple of 32. It's important to note that the P/E ratio offers a way to evaluate the stock price relative to the company's profits. However, since it is a backward-looking metric, it tends to struggle with companies that are growing profits quickly.
Such is the case with Palantir. In the first quarter, its revenue grew 85% year over year to $1.63 billion. This marked the fastest year-over-year growth rate thus far and the 11th consecutive quarter of accelerating revenue growth. Moreover, the company's expanding operating margin -- at 46% and growing -- sent more profits to the bottom line, driving Palantir's earnings per share (EPS) up 325% to $0.34, up from $0.08 in the prior-year quarter.
Given Palantir's accelerating growth as context, it's easy to see why the commonly used P/E ratio falls flat.
What Wall Street is saying Palantir recently held its AIPCon -- the company's customer-focused technology conference that uses real-world case studies to demonstrate the utility of its AI systems. More specifically, it highlights the benefits of ontology, Palantir's process for mapping its AI systems to siloed company data and physical operations. In doing so, the system taps a company's own data to create decision-making matrices, automate supply chains, optimize manufacturing operations, and much more.
UBS analyst Karl Keirstead attended AIPCon, interacting with Palantir's customers and their company executives, and believes investors' simplistic evaluations don't do Palantir justice. The analyst noted that the "complexity and depth" of its systems have no real competition.
Today's Change
(
7.84
%) $
9.15
Current Price
$
125.82
At the heart of his bullish take is that Palantir's offerings go far beyond "large language model (LLM) deployment, data ingestion, and semantic layers." Customers Keirstead spoke to said no LLM can replace Palantir for data workloads. One even suggested that AIP's ability to integrate deeply with complex systems and turn AI-driven insights into real-world solutions gives Palantir a "five-year moat."
Finally, the analyst said that at 46 times its 2027 estimated free cash flow (emphasis mine), "we believe Palantir shares are undervalued relative to medium-term growth."
I believe the analyst hit the nail on the head. Palantir recently raised its full-year forecast and is now guiding for revenue of $7.66 billion, which would represent year-over-year growth of 131%, driving adjusted operating income of $2.25 billion, an increase of 97%. Management is also guiding for free cash flow of $4.3 billion at the midpoint of its guidance, or growth of 89%.
My go-to metric for high-growth companies is the price/earnings-to-growth (PEG) ratio, which adjusts the P/E ratio for a company's expected earnings growth. This provides insight into whether a premium stock price is warranted. Palantir returns a multiple of 0.46, when any number less than 1 suggests a stock is undervalued. This metric supports the analyst's view.
If the analyst is right -- and I believe he is -- then Palantir has no real competition, and concerns about its premium valuation are unjustified. That said, the stock simply may not be for everyone.
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Roku (NASDAQ: ROKU) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Fox.
Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
Roku stockholders will receive cash-and-stock transaction valued at $160.00 per Roku share. Fox will pay $96.00 in cash and 0.9693 shares of Fox Class A common stock for each Roku Class A and Class B share. Upon closing, existing Fox shareholders are expected to own approximately 73% of the combined company and Roku shareholders approximately 27%.
Roku insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Roku by imposing a significant penalty if Roku accepts a competing bid. We are investigating the conduct of the Roku board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Here are three stocks with buy rank and strong income characteristics for investors to consider today, July 2:
Rockwell Automation, Inc. (ROK - Free Report) : This industrial automation company witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.9% the last 60 days.
This Zacks Rank #1 company has a dividend yield of 1.1%, compared with the industry average of 0.0%.
Cummins Inc. (CMI - Free Report) : This power solutions company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.6% the last 60 days.
This Zacks Rank #1 company has a dividend yield of 1.1%, compared with the industry average of 0.6%.
Analog Devices, Inc. (ADI - Free Report) : This integrated circuit company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.6% in the last 60 days.
This Zacks Rank #1 company has a dividend yield of 1.1%, compared with the industry average of 0.0%.
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
